BioSpace News Archive

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Pulmatrix, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Matthew L. Myers, President, Campaign for Tobacco-Free Kids In Support of Int-1345 and Int-1362

Oxford Gene Technology (OGT), The Molecular Genetics Company, has been granted de novo classification by the US Food and Drug Administration (FDA) for eight Cytocell Aquarius® Haematology fluorescence in situ hybridisation (FISH) probes for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS)

Dr. Qassim Abdullah, Ph.D., CP, PLS, was honored Tuesday night with the American Society for Photogrammetry and Remote Sensing (ASPRS) Lifetime Achievement Award.

The Honourable Jean‑Yves Duclos, Minister of Families, Children and Social Development, together with Mrs. Jennifer McCrea, announced that the Federal Court has approved a settlement agreement to resolve a class action between the federal government and parents who, between 2002 and 2013, applied for Employment Insurance (EI) sickness benefits while in receipt of EI parental benefits and were denied.

Summary notice of proposed settlement of class action, derivative claims, fairness hearing, and right to appear

The law sought to reform VA’s community care programs, including replacing the existing Choice program that sets the benchmark for access to care in the community.

Pre-launch U.S. product sales of A$1.1 million in second quarter

American Legion National Commander Brett Reistad offered support for the new access standards announced by the Department of Veterans Affairs today.